skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist


Citation Formats

Masureel, Matthieu, Zou, Yaozhong, Picard, Louis-Philippe, van der Westhuizen, Emma, Mahoney, Jacob P., Rodrigues, João P. G. L. M., Mildorf, Thomas J., Dror, Ron O., Shaw, David E., Bouvier, Michel, Pardon, Els, Steyaert, Jan, Sunahara, Roger K., Weis, William I., Zhang, Cheng, and Kobilka, Brian K. Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist. United States: N. p., 2018. Web. doi:10.1038/s41589-018-0145-x.
Masureel, Matthieu, Zou, Yaozhong, Picard, Louis-Philippe, van der Westhuizen, Emma, Mahoney, Jacob P., Rodrigues, João P. G. L. M., Mildorf, Thomas J., Dror, Ron O., Shaw, David E., Bouvier, Michel, Pardon, Els, Steyaert, Jan, Sunahara, Roger K., Weis, William I., Zhang, Cheng, & Kobilka, Brian K. Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist. United States. doi:10.1038/s41589-018-0145-x.
Masureel, Matthieu, Zou, Yaozhong, Picard, Louis-Philippe, van der Westhuizen, Emma, Mahoney, Jacob P., Rodrigues, João P. G. L. M., Mildorf, Thomas J., Dror, Ron O., Shaw, David E., Bouvier, Michel, Pardon, Els, Steyaert, Jan, Sunahara, Roger K., Weis, William I., Zhang, Cheng, and Kobilka, Brian K. Tue . "Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist". United States. doi:10.1038/s41589-018-0145-x.
@article{osti_1502205,
title = {Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist},
author = {Masureel, Matthieu and Zou, Yaozhong and Picard, Louis-Philippe and van der Westhuizen, Emma and Mahoney, Jacob P. and Rodrigues, João P. G. L. M. and Mildorf, Thomas J. and Dror, Ron O. and Shaw, David E. and Bouvier, Michel and Pardon, Els and Steyaert, Jan and Sunahara, Roger K. and Weis, William I. and Zhang, Cheng and Kobilka, Brian K.},
abstractNote = {},
doi = {10.1038/s41589-018-0145-x},
journal = {Nature Chemical Biology},
issn = {1552-4450},
number = 11,
volume = 14,
place = {United States},
year = {2018},
month = {10}
}

Works referenced in this record:

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy
journal, December 2009


Crystallizing Membrane Proteins for Structure Determination: Use of Lipidic Mesophases
journal, June 2009


The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
journal, January 2011

  • Warne, Tony; Moukhametzianov, Rouslan; Baker, Jillian G.
  • Nature, Vol. 469, Issue 7329
  • DOI: 10.1038/nature09746

Protection against allergen-induced asthma by salmeterol
journal, December 1990


Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β 2-Adrenergic Receptors
journal, March 2015

  • Gimenez, Luis E.; Baameur, Faiza; Vayttaden, Sharat J.
  • Molecular Pharmacology, Vol. 87, Issue 6
  • DOI: 10.1124/mol.114.096800

Bioluminescence resonance energy transfer-based biosensors allow monitoring of ligand- and transducer-mediated GPCR conformational changes
journal, August 2018

  • Picard, Louis-Philippe; Schönegge, Anne Marie; Lohse, Martin J.
  • Communications Biology, Vol. 1, Issue 1
  • DOI: 10.1038/s42003-018-0101-z

Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state
journal, October 2016

  • Schafer, Christopher T.; Fay, Jonathan F.; Janz, Jay M.
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 42
  • DOI: 10.1073/pnas.1606347113

Single-molecule analysis of ligand efficacy in β2AR–G-protein activation
journal, June 2017

  • Gregorio, G. Glenn; Masureel, Matthieu; Hilger, Daniel
  • Nature, Vol. 547, Issue 7661
  • DOI: 10.1038/nature22354

Structural Insights into the Dynamic Process of β 2 -Adrenergic Receptor Signaling
journal, May 2015


Regulation of β 2 -Adrenergic Receptor Function by Conformationally Selective Single-Domain Intrabodies
journal, December 2013

  • Staus, Dean P.; Wingler, Laura M.; Strachan, Ryan T.
  • Molecular Pharmacology, Vol. 85, Issue 3
  • DOI: 10.1124/mol.113.089516

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo
journal, November 1991


GPCR Engineering Yields High-Resolution Structural Insights into  2-Adrenergic Receptor Function
journal, October 2007


Pathway and mechanism of drug binding to G-protein-coupled receptors
journal, July 2011

  • Dror, Ron O.; Pan, Albert C.; Arlow, Daniel H.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 32
  • DOI: 10.1073/pnas.1104614108

Long-Acting ??2 Agonists in the Management of Stable Chronic Obstructive Pulmonary Disease
journal, January 2000


β-Arrestin-biased Agonism at the β 2 -Adrenergic Receptor
journal, December 2007

  • Drake, Matthew T.; Violin, Jonathan D.; Whalen, Erin J.
  • Journal of Biological Chemistry, Vol. 283, Issue 9
  • DOI: 10.1074/jbc.M708118200

Single-molecule FRET–derived model of the synaptotagmin 1–SNARE fusion complex
journal, February 2010

  • Choi, Ucheor B.; Strop, Pavel; Vrljic, Marija
  • Nature Structural & Molecular Biology, Vol. 17, Issue 3
  • DOI: 10.1038/nsmb.1763

The Dynamic Process of β2-Adrenergic Receptor Activation
journal, January 2013


Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody
journal, September 2013

  • Ring, Aaron M.; Manglik, Aashish; Kruse, Andrew C.
  • Nature, Vol. 502, Issue 7472
  • DOI: 10.1038/nature12572

GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
journal, August 2016


Synergistic Contributions of the Functional Groups of Epinephrine to Its Affinity and Efficacy at the β 2 Adrenergic Receptor
journal, April 2004

  • Liapakis, George; Chan, Wai Chi; Papadokostaki, Maria
  • Molecular Pharmacology, Vol. 65, Issue 5
  • DOI: 10.1124/mol.65.5.1181

Identification of two distinct inactive conformations of the  2-adrenergic receptor reconciles structural and biochemical observations
journal, March 2009

  • Dror, R. O.; Arlow, D. H.; Borhani, D. W.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 12
  • DOI: 10.1073/pnas.0811065106

Exosites: their current status, and their relevance to the duration of action of long-acting β2-adrenoceptor agonists
journal, September 1996

  • Coleman, Robert A.; Johnson, Malcolm; Niais, Anthony T.
  • Trends in Pharmacological Sciences, Vol. 17, Issue 9
  • DOI: 10.1016/0165-6147(96)10040-7

Salmeterol Stimulation Dissociates β 2 -Adrenergic Receptor Phosphorylation and Internalization
journal, February 2007

  • Moore, Robert H.; Millman, Ellen E.; Godines, Veronica
  • American Journal of Respiratory Cell and Molecular Biology, Vol. 36, Issue 2
  • DOI: 10.1165/rcmb.2006-0158OC

Salmeterol’s Extreme β 2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains
journal, October 2014

  • Baker, Jillian G.; Proudman, Richard G. W.; Hill, Stephen J.
  • Molecular Pharmacology, Vol. 87, Issue 1
  • DOI: 10.1124/mol.114.095364

Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.
journal, August 1996

  • Wieland, K.; Zuurmond, H. M.; Krasel, C.
  • Proceedings of the National Academy of Sciences, Vol. 93, Issue 17
  • DOI: 10.1073/pnas.93.17.9276

N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor
journal, October 2012


β2-adrenoceptor agonists: current and future direction: β-agonists in asthma and COPD
journal, April 2011


Structure of a nanobody-stabilized active state of the β2 adrenoceptor
journal, January 2011

  • Rasmussen, Søren G. F.; Choi, Hee-Jung; Fung, Juan Jose
  • Nature, Vol. 469, Issue 7329
  • DOI: 10.1038/nature09648

D RUG E FFICACY AT G P ROTEIN –C OUPLED R ECEPTORS
journal, April 2002


The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
journal, May 2009

  • Yao, X. J.; Velez Ruiz, G.; Whorton, M. R.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 23
  • DOI: 10.1073/pnas.0811437106

Activation and allosteric modulation of a muscarinic acetylcholine receptor
journal, November 2013

  • Kruse, Andrew C.; Ring, Aaron M.; Manglik, Aashish
  • Nature, Vol. 504, Issue 7478
  • DOI: 10.1038/nature12735

The risk of asthma mortality with inhaled long acting  -agonists
journal, September 2008

  • Wijesinghe, M.; Perrin, K.; Harwood, M.
  • Postgraduate Medical Journal, Vol. 84, Issue 995
  • DOI: 10.1136/pgmj.2007.067165

Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma
journal, June 2014


Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET
journal, July 2016

  • Namkung, Yoon; Le Gouill, Christian; Lukashova, Viktoria
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12178

Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding: MOLECULAR LOCALIZATION OF THE SALMETEROL EXOSITE WITHIN THE β
journal, September 1996

  • Green, Stuart A.; Spasoff, Andrew P.; Coleman, Robert A.
  • Journal of Biological Chemistry, Vol. 271, Issue 39
  • DOI: 10.1074/jbc.271.39.24029

Crystal structure of the β2 adrenergic receptor–Gs protein complex
journal, July 2011

  • Rasmussen, Søren G. F.; DeVree, Brian T.; Zou, Yaozhong
  • Nature, Vol. 477, Issue 7366
  • DOI: 10.1038/nature10361

Propagation of conformational changes during μ-opioid receptor activation
journal, August 2015

  • Sounier, Rémy; Mas, Camille; Steyaert, Jan
  • Nature, Vol. 524, Issue 7565
  • DOI: 10.1038/nature14680

Probing the Salmeterol Binding Site on the β 2 -Adrenergic Receptor Using a Novel Photoaffinity Ligand, [ 125 I]Iodoazidosalmeterol
journal, August 1999

  • Rong, Yajing; Arbabian, Marty; Thiriot, David S.
  • Biochemistry, Vol. 38, Issue 35
  • DOI: 10.1021/bi9910676

Version 1.2 of the Crystallography and NMR system
journal, October 2007


Rational Design of Receptor Partial Agonists and Possible Mechanisms of Receptor Partial Activation: A Theory
journal, August 1996


Quantification of Ligand Bias for Clinically Relevant β 2 -Adrenergic Receptor Ligands: Implications for Drug Taxonomy
journal, December 2013

  • van der Westhuizen, Emma T.; Breton, Billy; Christopoulos, Arthur
  • Molecular Pharmacology, Vol. 85, Issue 3
  • DOI: 10.1124/mol.113.088880

Allosteric regulation of G protein–coupled receptor activity by phospholipids
journal, November 2015

  • Dawaliby, Rosie; Trubbia, Cataldo; Delporte, Cédric
  • Nature Chemical Biology, Vol. 12, Issue 1
  • DOI: 10.1038/nchembio.1960

The pharmacology of salmeterol
journal, January 1993


A Close Look at Fluorescence Quenching of Organic Dyes by Tryptophan
journal, November 2005


Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
journal, February 2007

  • Calverley, Peter M. A.; Anderson, Julie A.; Celli, Bartolome
  • New England Journal of Medicine, Vol. 356, Issue 8
  • DOI: 10.1056/NEJMoa063070

Cardiovascular Safety of Salmeterol in COPDa
journal, June 2003


Characterization of Isoprenaline- and Salmeterol-Stimulated Interactions between β 2 -Adrenoceptors and β-Arrestin 2 Using β-Galactosidase Complementation in C2C12 Cells
journal, July 2005

  • Carter, Alison A.; Hill, Stephen J.
  • Journal of Pharmacology and Experimental Therapeutics, Vol. 315, Issue 2
  • DOI: 10.1124/jpet.105.088914

Structure and function of an irreversible agonist-β2 adrenoceptor complex
journal, January 2011

  • Rosenbaum, Daniel M.; Zhang, Cheng; Lyons, Joseph A.
  • Nature, Vol. 469, Issue 7329
  • DOI: 10.1038/nature09665

Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry
journal, February 2017

  • Fronik, Philipp; Gaiser, Birgit I.; Sejer Pedersen, Daniel
  • Journal of Medicinal Chemistry, Vol. 60, Issue 10
  • DOI: 10.1021/acs.jmedchem.6b01601